Riyadh, Saudi Arabia–The Saudi Ministry of Investment has signed two memorandums of understanding with Boehringer Ingelheim Company and Saudi Novo Nordisk Trading Company and King Abdullah University of Science and Technology at Riyadh Global Medical Biotechnology Summit 2023, the Saudi Press Agency reported Friday.
The MoUs were signed in the presence of Minister of Investment Eng. Khalid bin Abdulaziz Al-Falih, SPA said.
The summit was organized by the Ministry of National Guard represented by Health Affairs Department in Riyadh on January 25-26.
Also read: TRSDC of Saudi Arabia partners with an Austrian biotech firm to produce seafood
The two MoUs aim to enhance joint cooperation with the biotechnology and medicine sector in the Kingdom, transfer knowledge, localize the industry, contribute to enhancing human health and quality of life, increase awareness and establish centers specialized in research, SPA said.
The Ministry of Investment is a strategic partner to Riyadh Global Medical Biotechnology Summit 2023, which hosts a group of international experts to discuss the latest developments in medical biotechnology, it added.